Production (Stage)
InspireMD, Inc.
NSPR
$2.53
$0.2510.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.19% | 10.68% | 16.32% | 5.46% | 21.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.19% | 10.68% | 16.32% | 5.46% | 21.95% |
| Cost of Revenue | 1.48% | 17.83% | 24.87% | 21.59% | 40.76% |
| Gross Profit | 0.00% | -7.13% | -5.48% | -32.59% | -21.72% |
| SG&A Expenses | 51.41% | 43.60% | 25.06% | 36.11% | 74.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.54% | 49.50% | 42.77% | 43.58% | 58.81% |
| Operating Income | -54.57% | -61.28% | -50.06% | -55.41% | -69.23% |
| Income Before Tax | -58.79% | -70.69% | -52.38% | -55.78% | -65.23% |
| Income Tax Expenses | -- | -9.23% | -- | -- | -- |
| Earnings from Continuing Operations | -58.79% | -69.73% | -52.38% | -55.78% | -65.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -58.79% | -69.73% | -52.38% | -55.78% | -65.23% |
| EBIT | -54.57% | -61.28% | -50.06% | -55.41% | -69.23% |
| EBITDA | -54.69% | -61.68% | -50.37% | -55.87% | -69.79% |
| EPS Basic | -8.71% | -16.74% | -7.02% | 8.51% | 60.94% |
| Normalized Basic EPS | -8.81% | -14.47% | -7.04% | 8.50% | 60.97% |
| EPS Diluted | -8.71% | -16.74% | -7.02% | 8.51% | 61.25% |
| Normalized Diluted EPS | -8.81% | -14.47% | -7.04% | 8.50% | 60.97% |
| Average Basic Shares Outstanding | 46.00% | 45.39% | 42.33% | 70.25% | 323.10% |
| Average Diluted Shares Outstanding | 46.00% | 45.39% | 42.33% | 70.25% | 323.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |